This inventor holds 3 USPTO granted patents. Top assignees: Beecham Group Plc, Beecham Plc. Active years: 1983-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tadworth, GB (1983)
- Epsom, GB (1992 - 1993)
Company Filing History:
Years Active: 1983-1993
Title: The Innovative Contributions of David M Duckworth
Introduction
David M Duckworth is a notable inventor based in Epsom, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of 3 patents to his name, Duckworth's work has the potential to impact the treatment of viral infections.
Latest Patents
Among his latest patents are innovative compounds aimed at combating viral infections. One of his notable inventions is the "Antiviral purine compounds," which includes compounds of formula (I) and pharmaceutically acceptable salts thereof, where R₁ is hydroxy, amino, chloro, or OR₇. Another significant patent is the "Antiviral phosphonylalkoxy purines," which describes a compound of formula (I) or a pharmaceutically acceptable salt thereof, where R₁ is hydroxy or amino. These inventions showcase Duckworth's commitment to advancing antiviral therapies.
Career Highlights
Throughout his career, Duckworth has worked with prominent companies in the pharmaceutical industry, including Beecham Group Plc and Beecham Plc. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in drug development.
Collaborations
Duckworth has collaborated with several talented individuals in his field, including Michael R Harnden and Halina T Serafinowska. These collaborations have likely enriched his research and led to the successful development of his patented inventions.
Conclusion
David M Duckworth's contributions to antiviral research and his innovative patents highlight his role as a significant figure in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile